Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal

Abraham, 1988, Immunohistochemical identification of the serine protease inhibitor alpha-1 antichymotrypsin in the brain amyloid deposits of Alzheimer's disease, Cell, 52, 487, 10.1016/0092-8674(88)90462-X Aisen, 1995, Anti-inflammatory therapy for Alzheimer's disease, Dementia, 9, 173 Aisen, 1994, Inflammatory mechanisms in Alzheimer's disease: Implications for therapy, Am. J. Psychiatry, 151, 1105, 10.1176/ajp.151.8.1105 Altstiel, 1991, Cytokines in Alzheimer's disease, Biol. Psychiatry, 15, 481 Andersen, 1995, Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study, Neurology, 45, 1441, 10.1212/WNL.45.8.1441 Ban, 1994, Interleukin-1 receptors in the brain: Characterization by quantitative in situ autoradiography, Immunomethods, 5, 31, 10.1006/immu.1994.1035 Banati, 1993, Cytotoxicity of microglia, Glia, 7, 111, 10.1002/glia.440070117 Bauer, 1991, Interleukin-6 and alpha-2-macroglobulin indicate an acute phase response in Alzheimer's disease cortices, FEBS Lett., 285, 111, 10.1016/0014-5793(91)80737-N Bauer, 1992, The participation of interleukin-6 in the pathogenesis of Alzheimer's disease, Res. Immunol., 143, 650, 10.1016/0923-2494(92)80051-L Breitner, 1991, Clinical genetics and genetic counseling in Alzheimer's disease, Ann. Intern. Med., 115, 601, 10.7326/0003-4819-601 Breitner, 1994, New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause, Neurobiol. Aging, 150, S175, 10.1016/0197-4580(94)90199-6 Breitner, 1994, Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study, Neurology, 44, 227, 10.1212/WNL.44.2.227 Breitner, 1995, Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs, Neurobiol. Aging, 16, 523, 10.1016/0197-4580(95)00049-K Breteler, 1992, Epidemiology of Alzheimer's disease, Epidemiol. Rev., 14, 59, 10.1093/oxfordjournals.epirev.a036092 Breteler, 1991, Medical history and the risk of Alzheimer's disease: A collaborative reanalysis of case-control studies, Int. J. Epidemiol., 20, S36, 10.1093/ije/20.Supplement_2.S36 Broe, 1990, A case-control study of Alzheimer's disease in Australia, Neurology, 40, 1698, 10.1212/WNL.40.11.1698 Choi, 1988, Glutamate neurotoxicity and diseases of the nervous system, Neuron, 1, 623, 10.1016/0896-6273(88)90162-6 Chui, 1994, Decreased β-amyloid and increased abnormal tau deposition in the brain of aged patients with leprosy, Am. J. Pathol., 145, 771 Colton, 1987, Production of superoxide anions by a CNS macrophage, the microglia, FEBS Lett., 223, 284, 10.1016/0014-5793(87)80305-8 Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 Cordell, 1994, B-Amyloid formation as a potential therapeutic target forAlzheimer's disease, Annu. Rev. Pharmacol. Toxicol., 34, 69, 10.1146/annurev.pa.34.040194.000441 Corradin, 1993, Inducible nitric oxide synthase activity of cloned murine microglial cells, Glia, 7, 255, 10.1002/glia.440070309 Eikelenboom, 1989, Complement activation in amyloid plaques in Alzheimer's dementia, Virchows Arch. B. Cell Pathol., 56, 259, 10.1007/BF02890024 Einstein, 1995, Distribution of apoE-immunoreactive neurons in control and AD brains, Soc. Neurosci. Abstr., 21, 1008 Fillit, 1991, Elevated circulating tumor necrosis factor levels in Alzheimer's disease, Neurosci. Lett., 129, 318, 10.1016/0304-3940(91)90490-K Fratiglioni, 1993, Epidemiology of Alzheimer's disease. Issues of etiology and validity, Acta Neurol. Scand., 87, 1 Frederickson, 1992, Astroglia in Alzheimer's disease, Neurobiol. Aging, 13, 239, 10.1016/0197-4580(92)90036-W Frederickson, 1994, New opportunities in AD research—Roles of immunoinflammatory responses and glia, Alzheimer Dis. Assoc. Disorders, 8, 159, 10.1097/00002093-199408030-00002 Giulian, 1993, Reactive glia as rivals in regulating neuronal survival, Glia, 7, 102, 10.1002/glia.440070116 Goldgaber, 1989, Interleukin-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells, 86, 7606 Gottschall, 1994, Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: Synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP), Brain Res., 637, 197, 10.1016/0006-8993(94)91233-5 Graves, 1990, A case-control study of Alzheimer's disease, Ann. Neurol., 28, 766, 10.1002/ana.410280607 Graves, 1990, The association between head trauma and Alzheimer's disease, Am. J. Epidemiol., 131, 491, 10.1093/oxfordjournals.aje.a115523 Griffin, 1989, Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, 86, 7611 Haga, 1993, Synthetic Alzheimer amyloid/A4 peptides enhance production of complement C3 component by cultured microglial cells, Brain Res., 601, 88, 10.1016/0006-8993(93)91698-R Hansen, 1988, Neocortical morphometry, lesion counts and choline acetyltransferase levels in the age spectrum of Alzheimer's disease, Neurology, 38, 48, 10.1212/WNL.38.1.48 Hebert, 1992, Relation of smoking and alcohol consumption to incident Alzheimer's disease, Am. J. Epidemiol., 135, 347, 10.1093/oxfordjournals.aje.a116296 Henderson, 1990, Epidemiology of dementing disorders, 15 Henderson, 1992, Environmental risk factors for Alzheimer's disease: Their relationship to age of onset and to familial or sporadic types, Psychol. Med., 22, 429, 10.1017/S0033291700030373 Heyman, 1984, Alzheimer's disease: A study of epidemiological aspects, Ann. Neurol., 15, 335, 10.1002/ana.410150406 Holstein, 1994, Prevalence of associated diseases in different types of dementia among elderly institutionalized patients; Analysis of 3447 records, J. Am. Geriatr. Soc., 42, 972, 10.1111/j.1532-5415.1994.tb06590.x Jenkinson, 1989, Rheumatoid arthritis and senile dementia of the Alzheimer's type, Br. J. Rheumatol., 28, 86, 10.1093/rheumatology/28.1.86-b Jorm, 1991, Psychiatric history and related exposures as risk factors for Alzheimer's disease: A collaborative reanalysis of case-control studies, Int. J. Epidemiol., 20, S43, 10.1093/ije/20.Supplement_2.S43 Katsuura, 1989, Interleukin 1-β increases prostaglandin E2 in rat astrocyte cultures: Modulatory effect of neuropeptides, Endocrinology, 124, 3125, 10.1210/endo-124-6-3125 Katzman, 1988, Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques, Ann. Neurol., 23, 138, 10.1002/ana.410230206 Koh, 1990, Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage, Brain Res., 533, 315, 10.1016/0006-8993(90)91355-K Kukull, 1994, Nonsteroidal anti-inflammatory drug use and risk of Alzheimer's disease, Neurology, 44, A237 Lerea, 1993, Inotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signaling pathways, Neuron, 10, 31, 10.1016/0896-6273(93)90239-N Li, 1992, A case-control study of Alzheimer's disease in China, Neurology, 42, 1481, 10.1212/WNL.42.8.1481 Lucca, 1994, Nonsteroidal anti-inflammatory drug use in Alzheimer's disease, Biol. Psychiatry, 36, 854, 10.1016/0006-3223(94)90598-3 Lue, 1992, Full complement activation fails in diffuse plaques of the Alzheimer's disease cerebellum, Dementia, 3, 308 Madison, 1991, Mechanisms underlying long-term potentiation of synaptic transmission, Annu. Rev. Neurosci., 14, 379, 10.1146/annurev.ne.14.030191.002115 Mayeux, 1995, Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease, Neurology, 45, 555, 10.1212/WNL.45.3.555 Mayeux, 1993, Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives, Ann. Neurol., 33, 494, 10.1002/ana.410330513 McDowell, 1994, The Canadian study of health and aging: Risk factors for Alzheimer's disease in Canada, Neurology, 44, 2073, 10.1212/WNL.44.11.2073 McGeer, 1989, Immune system response in Alzheimer's disease, Can. J. Neurol. Sci., 16, 516, 10.1017/S0317167100029863 McGeer, 1992, Prevalence of dementia amongst elderly Japanese with leprosy apparent effect of chronic drug therapy, Dementia, 3, 146 McGeer, 1993, Microglia in degenerative neurological disease, Glia, 7, 84, 10.1002/glia.440070114 McGeer, 1995, Chronic inflammatory mechanisms of the brain: Implications for the treatment of Alzheimer disease, Dementia, 9, 111 McGeer, 1990, Anti-inflammatory drugs and Alzheimer disease, Lancet, 335, 1037, 10.1016/0140-6736(90)91101-F McGeer, 1994, Neuroimmune mechanisms in Alzheimer disease pathogenesis, Alzheimer Dis. Assoc. Disord., 8, 149, 10.1097/00002093-199408030-00001 Mortimer, 1995 Mortimer, 1991, Head trauma as a risk factor for Alzheimer's disease: A collaborative reanalysis of case-control studies, Int. J. Epidemiol., 20, S28, 10.1093/ije/20.Supplement_2.S28 Mrak, 1995, Glial cytokines in Alzheimer's disease: Review and pathogenetic implications, Hum. Pathol., 26, 816, 10.1016/0046-8177(95)90001-2 Myllykangas-Luosujarvi, 1994, Alzheimer's disease and rheumatoid arthritis, Br. J. Rheumatol., 33, 501, 10.1093/rheumatology/33.5.501 Nietro-Sampredo, 1987, Astrocyte mitogenic activity in aged normal and Alzheimer's human brain, Neurobiol. Aging, 8, 249, 10.1016/0197-4580(87)90009-1 Norris, 1993, Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine, J. Neuroimmunol., 45, 137, 10.1016/0165-5728(93)90174-W O'Banion, 1992, cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase, 89, 4888 Oltersdorf, 1989, The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II, Nature, 341, 144, 10.1038/341144a0 Steffens, D. C.; Plassman, B. L.; Helms, M. J.; Welsh, K. A.; Saunders, A. M.; Breitner, J. C. S. A twin study of late-onset depression and apolipoprotein E ϵ4 as risk factors for Alzheimer's disease. Biol. Psychiatry. (in press). Rich, 1995, Nonsteroidal anti-inflammatory drugs in Alzheimer's disease, Neurology, 45, 51, 10.1212/WNL.45.1.51 Roberts, 1994, β-Amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease, J. Neurol., 57, 419 Rogers, 1993, Clinical trial of indomethacin in Alzheimer's disease, Neurology, 43, 1609, 10.1212/WNL.43.8.1609 Roses, 1994, The Alzheimer diseases, vol. 14, 111 Rozemuller, 1989, Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family, Neurosci. Lett., 101, 288, 10.1016/0304-3940(89)90547-8 Rozemuller, 1990, Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease, Neurosci. Lett., 109, 75, 10.1016/0304-3940(90)90759-3 Rubio, 1994, Demonstration of the presence of interleukin-1 receptor on the surface of murine astrocytes and its regulation by cytokines and Theiler's virus, Immunology, 82, 178 Satz, 1993, Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory, Neuropsychology, 7, 273, 10.1037/0894-4105.7.3.273 Schofield, 1995, The age at onset of Alzheimer's disease and an intracranial area measurement, Arch. Neurol., 52, 95, 10.1001/archneur.1995.00540250103019 Smeyne, 1993, Continuous c-fos expression precedes programmed cell death in vivo, Nature, 363, 166, 10.1038/363166a0 Smith, 1991, The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways, 297 Smith, 1991, Prostaglandin endoperoxide synthase: Structure and catalysis, Biochim. Biophys. Acta, 1083, 1, 10.1016/0005-2760(91)90119-3 Soll, 1991, Nonsteroidal anti-inflammatory drugs and peptic ulcer disease, Ann. Intern. Med., 114, 307, 10.7326/0003-4819-114-4-307 Stern, 1994, Influence of education and occupation on the incidence of Alzheimer's disease, JAMA, 271, 1004, 10.1001/jama.271.13.1004 Strittmatter, 1994, Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype, Exp. Neurol., 125, 163, 10.1006/exnr.1994.1019 Sunami, 1991, Two aspects of the excitatory influence of histamine on hippocampal neurons in guinea pigs, Methods Find. Exp. Clin. Pharmacol., 13, 85 van Duijn, 1992, Head trauma and the risk of Alzheimer's disease, Am. J. Epidemiol., 135, 775, 10.1093/oxfordjournals.aje.a116364 Vane, 1994, Towards a better aspirin, Nature, 367, 215, 10.1038/367215a0 Vane, 1987, Inflammation and the mechanism of action of anti-inflammatory drugs, FASEB J., 11, 89, 10.1096/fasebj.1.2.3111928 Vaughn, 1991, Eicosanoid-induced inhibition of glutamate uptake in cortical astrocytes, Soc. Neurosci. Abstr., 17, 55 Wagstaff, 1994, Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease, Drugs Aging, 4, 510, 10.2165/00002512-199404060-00006 Walker, 1995, Complement and cytokine gene expression in cultured microglia derived from postmortem human brains, J. Neurosci. Res., 40, 478, 10.1002/jnr.490400407 Zhang, 1990, The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education, Ann. Neurol., 27, 428, 10.1002/ana.410270412